Clinical Trial Update: Spirulina Platensis for PPI Withdrawal [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating spirulina platensis for withdrawal from proton pump inhibitors in gastroesophageal reflux disease and dyspepsia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia
• Gastroesophageal Reflux Disease

Drugs mentioned

• Spirulina Platensis

Snippet

Sponsor: Universidade de Passo Fundo | Conditions: Gastro Esophageal Reflux Disease, Dyspepsia | Phase 2 | Status: COMPLETED